Baxter International (NYSE:BAX) Price Target Raised to $44.00

Baxter International (NYSE:BAX – Get Free Report) had its price target boosted by stock analysts at Citigroup from $41.00 to $44.00 in a report issued on Wednesday, Benzinga reports. The firm currently has a “neutral” rating on the medical instruments supplier’s stock. Citigroup’s target price points to a potential upside of 1.62% from the company’s […]

Related Keywords

United States ,America , ,Citigroup ,Pzena Investment Management ,News Ratings For Baxter International Daily ,York Mellon Corp ,Jpmorgan Chase Co ,Analyst Recommendations For Baxter International ,Baxter International Inc ,Baxter International Company Profile ,Geode Capital Management ,Barclays ,Ameriprise Financial Inc ,Baxter International ,Baxter International Stock ,Get Free Report ,Capital Management ,New York Mellon Corp ,International Inc ,Medical Products ,Healthcare Systems ,Baxter International Daily ,Nyse Bax ,Bax ,Medical ,07181310 ,Boost Price Target ,Citigroup Inc ,